LH Labcorp Holdings Inc.

370.23USD+0.36%Mkt Cap: 29.95B USDP/E: 30.24

Labcorp Holdings Inc. provides laboratory services. It operates in Diagnostics Laboratories and Biopharma Laboratory Services segments. The company offers various tests, such as blood chemistry analyses, urinalyses, bloo…

Insiders, last 90 daysNet sellers
Institutional holders20 on file

Key Statistics

Company
Market Cap29.95B USD
Enterprise Value36.56B USD
Revenue (TTM)14.59B USD
Gross Profit4.01B USD
Net Income (TTM)876.50M USD
Revenue/Share178.15 USD
Last Price370.23 USD
Fiscal Year EndDec 2025
MR QuarterSep 2026
Employees71.0K
CountryUS
SectorHealthcare
IndustryDiagnostics & Research
ISIN—
Valuation
P/E (Trailing)30.24
P/E (Forward)18.82
PEG1.64
EV/EBITDA15.59
EV/Revenue2.50
P/S2.05
P/B3.39
EPS (TTM)12.20 USD
EPS (Forward)19.60 USD
52W Range
245.0096% of range375.10
52W High375.10 USD
52W Low245.00 USD
Profitability
Gross Margin28.76%
Oper. Margin11.18%
EBITDA Margin16.07%
Profit Margin6.28%
ROE10.17%
ROA4.77%
ROIC8.21%
ROCE9.74%
Growth
Revenue Growth6.90%
Earnings Growth3.20%
Cash Flow & Leverage
Operating CF1.64B USD
CapEx (TTM)434.50M USD
FCF Margin7.24%
FCF Yield3.53%
Net Debt6.59B USD
Net Debt/EBITDA2.81
Net Debt/FCF6.23
Balance Sheet
Debt/Equity0.76
Current Ratio1.41
Quick Ratio1.00
Book Value/Sh108.96 USD
Cash/Share3.22 USD
Dividends
Fwd Div Rate2.88 USD
Trail. Div Rate2.88 USD
Div. Yield0.78%
5Y Avg Yield0.96%
Payout Ratio23.61%
Ex-Div DateNov 24, 2026
Pay DateDec 11, 2026
Splits
Last Split1164:1000
Split DateJul 3, 2023
Analyst Consensus
Rating1.6 (Buy)
Strong BuyBuyHoldSellStr. Sell
Target (Mean)390.06 USD
Upside (mean)+5.4%
Target Range347.00 USD – 420.00 USD
347.00+5.4% to mean420.00
# Analysts16
Ownership
Shares Out.81.20M
Float80.81M
Insiders0.37%
Institutions100.22%
Short Interest
Short Ratio3.5d
Short % Float3.14%
Short % Out.3.13%
Shares Short2.54M
Short (prev mo.)2.68M
Technical
SMA 50332.41 (+11.4%)
SMA 200293.90 (+26.0%)
Beta0.83
S&P 52W Chg12.00%
Avg Vol (30d)697.89K
Avg Vol (10d)639.03K
Technical Indicators
RSI (14)64.5
MACD11.3869
MACD Signal12.2757
MACD Hist.-0.8888
BB Upper390.26 USD
BB Middle361.25 USD
BB Lower332.25 USD
BB Width16.06%
ATR (14)8.331 USD
Vol Ratio (20d)0.86x

About Labcorp Holdings (NYSE: LH)

›

Labcorp Holdings (NYSE: LH) is listed on the New York Stock Exchange, where its shares trade in USD. It belongs to the Diagnostics & Research industry, part of the Healthcare sector, and reports about 71,000 employees.

The shares were at 370.23 USD on 20 November 2026, up 41.9% over 52 weeks. Its 52-week range is 245.00 USD to 375.10 USD: the price is 1.3% below the high and 51.1% above the low.

At a market capitalisation of 29.95B USD, it trades at 30.2 times trailing earnings and 18.8 times forward earnings. The median trailing P/E of its 18 largest Diagnostics & Research peers is 35.8, a discount of 15% for LH. It pays a dividend yielding 0.78% (it pays out 24% of its earnings), against a median of 0.73% among the dividend payers in that peer group.

Labcorp Holdings reports return on equity of 10.2%, an operating margin of 11.2% and revenue up 6.9% year over year.

Its debt exceeds its cash by 6.59B USD, a debt-to-equity ratio of 0.76. Its Piotroski F-score is 8 out of 9, a strong reading of its financial health. 16 analysts cover the stock, with an average rating of Buy; their mean price target of 390.06 USD is 5.4% above the current price. The next earnings report is expected on 23 February 2027.